These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8904991)

  • 21. Advances in the pharmacotherapy of alcoholism: challenging misconceptions.
    Kranzler HR; Koob G; Gastfriend DR; Swift RM; Willenbring ML
    Alcohol Clin Exp Res; 2006 Feb; 30(2):272-81. PubMed ID: 16441276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet serotonin levels in alcoholic patients: changes related to physiological and pathological factors.
    Bailly D; Vignau J; Racadot N; Beuscart R; Servant D; Parquet PJ
    Psychiatry Res; 1993 Apr; 47(1):57-88. PubMed ID: 8516417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurobehavioral aspects of the pharmacotherapy of alcohol dependence.
    Anton RF; Kranzler HR; Meyer RE
    Clin Neurosci; 1995; 3(3):145-54. PubMed ID: 8612059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictions.
    Rothman RB; Blough BE; Baumann MH
    AAPS J; 2007 Jan; 9(1):E1-10. PubMed ID: 17408232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacotherapy of alcohol dependence: a review of the clinical data.
    Mann K
    CNS Drugs; 2004; 18(8):485-504. PubMed ID: 15182219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alcohol dependence and gene x environment interaction in emotion regulation: Is serotonin the link?
    Lesch KP
    Eur J Pharmacol; 2005 Dec; 526(1-3):113-24. PubMed ID: 16288736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central serotonergic lesions increase voluntary alcohol consumption in Sprague Dawley rats: moderation by long-term ethanol administration.
    Wang JY; Shum AY; Lin TC; Wang Y
    Alcohol Clin Exp Res; 1996 Oct; 20(7):1252-9. PubMed ID: 8904979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychotherapeutic considerations in pharmacological trials.
    O'Malley SS; Carroll KM
    Alcohol Clin Exp Res; 1996 Oct; 20(7 Suppl):17A-22A. PubMed ID: 8904990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacotherapy for alcohol dependence.
    West SL; Garbutt JC; Carey TS; Lux LJ; Jackman AM; Tolleson-Rinehart S; Lohr KN; Crews FT
    Evid Rep Technol Assess (Summ); 1999 Jan; (3):1-5. PubMed ID: 11487800
    [No Abstract]   [Full Text] [Related]  

  • 30. Serotonin function in panic disorder: important, but why?
    Maron E; Shlik J
    Neuropsychopharmacology; 2006 Jan; 31(1):1-11. PubMed ID: 16132063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacological treatment options for prevention of alcohol relapse].
    Heberlein A; Bleich S; Kornhuber J; Hillemacher T
    Fortschr Neurol Psychiatr; 2008 Jul; 76(7):421-8. PubMed ID: 18604776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of serotonergic agents as treatments for alcoholism.
    Johnson BA
    Drugs Today (Barc); 2003 Sep; 39(9):665-72. PubMed ID: 14586482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonergic Systems in the Pathophysiology of Ethanol Dependence: Relevance to Clinical Alcoholism.
    Marcinkiewcz CA
    ACS Chem Neurosci; 2015 Jul; 6(7):1026-39. PubMed ID: 25654315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Physiologic and therapeutic importance of serotonin and the serotonergic system].
    Molderings GJ
    Arzneimittelforschung; 2002; 52(3):145-54. PubMed ID: 11963640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive dysfunction in neuropsychiatric disorders: selected serotonin receptor subtypes as therapeutic targets.
    Terry AV; Buccafusco JJ; Wilson C
    Behav Brain Res; 2008 Dec; 195(1):30-8. PubMed ID: 18241938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recommended drug treatment strategies for the alcoholic patient.
    Schaffer A; Naranjo CA
    Drugs; 1998 Oct; 56(4):571-85. PubMed ID: 9806104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gamma-aminobutyric acid type A receptors and alcoholism: intoxication, dependence, vulnerability, and treatment.
    Krystal JH; Staley J; Mason G; Petrakis IL; Kaufman J; Harris RA; Gelernter J; Lappalainen J
    Arch Gen Psychiatry; 2006 Sep; 63(9):957-68. PubMed ID: 16952998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluvoxamine and alcoholism.
    Thomas R
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():85-90; discussion 90-2. PubMed ID: 1806637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological and genetic interventions in serotonin (5-HT)(2C) receptors to alter drug abuse and dependence processes.
    Filip M; Spampinato U; McCreary AC; Przegaliński E
    Brain Res; 2012 Oct; 1476():132-53. PubMed ID: 22494568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacotherapy in alcoholism.
    Miller NS
    J Addict Dis; 1995; 14(1):23-46. PubMed ID: 7632745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.